Option chain shows key data for Shanghai Fosun's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Shanghai Fosun.

Shanghai Fosun (OTC:SFOSF) Stock, Option Chain

Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Biotech

News

Health Care

General

BNTX

SFOSF

Taiwan Puts BioNTech Vaccine Deal On Hold Due To Pressure From China: Bloomberg

Penny Stocks

Retail Sales

Media

Millions of doses of Pfizer Inc (NYSE: PFE) and BioNTech SE’s  (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg 

China Secures 100M Doses Of Pfizer-BioNTech COVID-19 Vaccine For 2021

MRNA

NVAX

The whole world is coming together in the fight against COVID-19. The quest for a vaccine is revolutionizing the controversial Big Pharma. Nearly 200 vaccine candidates are in development, 39 in human clinical trials and nine in Phase III trials.

Big Pharma&#39;s Vaccine Race – A Chance For Redemption

Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H

Comments

Shanghai Fosun

Shanghai Fosun (SFOSF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga